Funding Archive
Baylor / U. T. M. D. Anderson Cancer Centers
Collaborative Multidisciplinary Research Program
General Information
The purpose of the Baylor / U. T. M. D. Anderson Cancer Centers Multidisciplinary Research Program (BCM / MDACC MRP) is to foster inter-institutional multidisciplinary collaborative translational research projects that engage multiple disciplines within and across the basic and clinical sciences. The aim of the program is to bring together research strengths across the two participating institutions to work on hypothesis-driven projects that have the potential to develop into large multi-project grants such as a SPORE or a P01.
Proposed programs should be designed as P01 or SPORE programs, with the following
components included:
- Leadership by a funded and established PI
- Multiple related projects supporting a single hypothesis-driven goal
- Core resources necessary to support the projects
We will award at least one MRP per year for each of 3 years. Each award will be for 2 ½ years of funding, for total project funding of $250,000. Funding is generally awarded as $100,000 in each of the first two years of funding, with the balance awarded in the third year. There are no restrictions on how the budget dollars are spent, however your budget must be well-justified.
MRP Proposal Process
The deadline for receipt of MRP proposals is January 15, 2008. Proposals may be submitted to Jenny Tektiridis (jtektir@mdanderson.org) in the Office of Translational Research, MDACC, or to e Administrative Offices of the Dan L. Duncan Cancer Center. It is strongly suggested that before submitting an MRP proposal, interested faculty have a pre-submission meeting with Dr. Robert Bast, MDACC, or Dr. Kent Osborne, BCM to discuss the MRP process and their proposal plans. Note: you do not have to initiate a pre-award research checklist for this proposal, nor do you need to establish inter-institutional consortium agreements. These will be established at the time of award and only need to be completed by award recipients.
Dan L. Duncan Cancer Center
Pilot Project Grant Announcement
July, 2007
The Dan L. Duncan Cancer Center will be coordinating a range of pilot projects open to all Cancer Center members funded through the Duncan Gift. We are seeking proposals that cover the full range of cancer investigation along the translational continuum including basic, pre-clinical, clinical and population based or epidemiological research. Individual pilot programs may require more focus.
All proposals will require project descriptions, limited to 6 pages not including references, to be written in the standard NIH grant format. The applications should include specific aims, background & significance, preliminary studies, research design & methods, as well as a few references, a budget and budget justification, biographical sketches and another support page. All proposals will be evaluated by peer review and scored in a manner that simulates the NIH peer review process. Cancer Center leadership may direct some awards in a way that assures balanced distribution of projects across programmatic and thematic spectrums or supports strategic aims.
Instructions for the Pilot Grant
Pilot Grant Proposal Submission Document
Following are the descriptions of the specific Pilot Fund programs.
Cancer Prevention and Population Sciences Pilot Projects
The Dan L. Duncan Cancer Center requests proposals for pilot project grants in the area of Cancer Prevention and Population Sciences. Areas of interest include cancer genetics, cancer epidemiology, molecular epidemiology, nutrition and dietary studies relating to cancer, minority health and disparities, cancer screening, risk assessment and outreach, and cancer preventative therapy. For questions pertaining to this program, please contact Dr. Powel Brown at 713.798.1609 or pbrown@breastcenter.tmc.edu. Applications will be accepted from any Baylor faculty. Funded investigators must be willing to become a Cancer Center member.
Approximately 4 one year grants will be awarded. Proposals cannot exceed $70,000 in total costs. No indirect costs will be required.
Deadline for Submittal is September 3, 2007.
Duncan Inter and Intra Programmatic Pilot Projects
The Dan L. Duncan Cancer Center is seeking proposals that will increase interactions between investigators who are members of the Molecular Carcinogenesis Program (Dr. Janet Butel), Cancer Biology Program (Dr. Larry Donehower) and the Prevention and Population Science Program (Dr. Powel Brown), and other cancer center members. Proposals will require at least two investigators – each from either a different focus group within one of the identified programs, or one investigator from an identified program and another investigator who may be aligned with a program, or an unaligned member. Consideration will be given to proposals that have a good potential to develop into externally funded multi investigator grants.
Approximately 4 one year grants of $70,000 will be awarded in this category. Proposals cannot exceed $70,000 in total costs. No indirect costs will be required.
Deadline for Submittal is September 3, 2007.
Duncan Inter-Institutional Pilot Projects
The Dan L. Duncan Cancer Center is seeking proposals that support interactions with investigators from other institutions. These proposals will require a member of the Cancer Center to partner with a co- investigator at another Texas Medical Center institution such as MD Anderson, Rice University, or UT Houston as well as UTMB. Proposals can cover any aspect of cancer investigation along the translational continuum including basic, pre-clinical, clinical and population based or epidemiological research. Consideration will be given to those proposals with comparable matching support from partner institutions or leverage additional external funding to support the interaction. For questions pertaining to this program, please contact Dr. C. Kent Osborne at 713.798.1641 or email kosborne@bcm.edu.
Funds in these proposals can be used to support any expenses on the BCM side of any interaction including BCM staff salary support, supplies, but major equipment purchases or PI salary are not allowed.
Approximately 2 one year grants of $70,000 will be awarded in this category. Proposals cannot exceed $70,000 in total costs. No indirect costs will be required.
Deadline for Submittal is September 3, 2007.
For general questions, please contact the Dan L. Duncan Cancer Center Administrative Office at 713.798.1354.
ACS-IRG Seed Funds for Cancer Research
The Dan L. Duncan Cancer Center is pleased to announce the availability of seed funds from the American Cancer Society Institutional Research Grant (IRG) #93-034-12. The funds support promising new cancer-related research projects by junior faculty. One-year grants in the amount of $30,000 will be awarded. Two projects will be open to any area of investigation with one reserved for special interest for population based or health disparities research.
Applicants must be full-time, tenure-track assistant professors, appointed during the past five years (on or after January 1, 2001), who do not hold independent, nationally competitive research grants. Please submit your application electronically to cancercenter@bcm.edu by Monday, August 13, 2007:
American Cancer Society Allowable Expenses
ACS-IRG Medical Student Stipend
A $2,500 stipend from the College’s American Cancer Society IRG #93-034-23 is also available to a medical student to spend time in a research laboratory while still employed in his or her degree program. The research must be related to cancer
Please submit to The Dan L. Duncan Cancer Center by Monday, August 13, 2007:
- One-page application outlining the proposed research
- Letter of recommendation from the mentor supervising the research
- Personal Statement (not to exceed one page)
- Official Medical School Transcript
2007 ACS Medical Student Stipend Application
Please contact Shari Stark at 798.2087 or email sharir@bcm.edu for additional information.
Helis Foundation Grants
The Cancer Center has established a relationship with the Helis Foundation. This past year 2 grants were funded for $100,000 each. Cancer Center Leadership expects three such grants to be available in this coming year. Helis Foundation review will be required for this grants, and a deadline for submittal has not yet been established.
Building Interdisciplinary Research Careers in Women's Health
http://grants.nih.gov/grants/guide/rfa-files/RFA-OD-05-002.html
RFA Number: RFA-OD-05-002
Release Date: November 24, 2004
Letters of Intent Receipt Date(s): January 22, 2005
Application Receipt Date(s): February 23, 2005
Peer Review Date(s): June/July 2005
Council Review Date(s): September 2005
Earliest Anticipated Start Date: September 30, 2005
Executive Summary
The NIH Office of Research on Women's Health (ORWH) and its cosponsors invite institutional career development award applications for Building Interdisciplinary Research Careers in Women's Health (BIRCWH) Career Development Programs, hereafter termed "Programs." Programs will support research career development of junior faculty members, known as Interdisciplinary Women's Health Research (IWHR) Scholars, who have recently completed clinical training or postdoctoral fellowships, and who are commencing basic, translational, behavioral, clinical and/or health services research relevant to women's health.
The goal of this initiative is to promote the performance of interdisciplinary research and transfer of findings that will benefit the health of women, including sex/gender similarities or differences in biology, health or disease. The programs will accomplish these goals by bridging advanced training with research independence, as well as bridging scientific disciplines or areas of interest. This will increase the number and skills of investigators at awardee institutions through a mentored research and career development experience leading to an independent interdisciplinary scientific career addressing women's health.
The NIH Institutes and Centers support biomedical and behavioral research and research training. The Agency for Healthcare Research and Quality (AHRQ) supports health services research and research training. The cosponsors are partnering with ORWH to support the career development of researchers in women's health within their respective missions.
Distinguished Achievement Award (Cancer)
NOTE: Faculty interested in applying for this award must have an acceptance letter from the Faculty Committee on Awards prior to submitting an application to the sponsor. For more information, please contact Michelle Almarez (798-6975) or Emily Hughes (798-6394) in the Office of Research.
The Faculty Committee on Awards requests nominations for the 2006 Freedom to Discover Award for Distinguished Achievement in Cancer Research sponsored by Bristol-Myers Squibb. This award is given to a scientist who has made an outstanding contribution to progress in cancer research in either laboratory or clinical studies. The award consists of $50,000 and a silver commemorative medallion.
Please distribute this award announcement to faculty in your department. If you wish to post or view a program flyer including detailed program information, please visit the following link: http://intranet.bcm.tmc.edu/index.cfm?tmp=research/oor/faaward/BMSCancer.pdf
To nominate someone, please send his or her curriculum vitae and a letter of nomination outlining the individual's relevant achievements to Rachel Cook at awards@bcm.edu by September 15, 2005.
For further information on this or other funding opportunities, visit our website
If you know anyone who would like to join this research listserv, please ask them to send their request to subscribe to awards@bcm.edu
Ruth Anne Eatock, Ph.D.
Chair, Faculty Committee on Awards
Alliance for Cancer Gene Therapy Announces Request for Applications
Deadline: February 23, 2005
The Alliance for Cancer Gene Therapy funds research aimed at furthering the development of gene therapy approaches to the treatment of cancer.
As part of this mission, AGCT invites applications for its 2005 ACGT Gene Therapy for Lymphoma & Leukemia Award pro- gram. The overall objectives of the program are to advance gene therapy into the causes, treatment, and prevention of lymphoma and leukemia by promoting basic, pre-clinical and clinical translational research approaches utilizing cells and genes as medicine. ACGT will direct the awards to gene therapy research that has demonstrated great promise, particularly those that are closer to clinical translation.
Candidates for the Gene Therapy for Lymphoma & Leukemia Award must hold an M.D., Ph.D., or equivalent degree and be a tenure-track or tenured faculty. The investigator must also be conducting original research as an indepen- dent faculty member. Although there are no citizenship restrictions, research supported by the award must be conducted at medical schools and research centers in the United States.
Grants of up to $1 million will be awarded over a period of three to five years (inclusive of a maximum of 10 percent indirect costs).
Visit the AGCT Web site to download the complete Request for Applications.
RFP Link: http://acgtfoundation.org/
For additional RFPs in Medical Research, visit: http://fdncenter.org/pnd/rfp/cat_medical_research.jhtml
Leukemia & Lymphoma Society Invites Applications for Translational Research Program
Deadline: March 1, 2005 (Preliminary application)
The Leukemia & Lymphoma Society ( http://www.lls.org/ ), a national health organization that sponsors research on leukemia, lymphoma, and myeloma, announces a call for preliminary applications for its Translational Research Program.
The program is designed to encourage and provide early- stage support for clinical research in leukemia, lymphoma, and myeloma that leads to the development of innovative approaches to treatment, diagnosis, and/or prevention. The program also fosters collaboration between basic and clinical scientists with the intent of enhancing the transfer of basic research findings to clinical usefulness. The program's purpose is to fund research that shows high promise for translating basic biomedical knowledge to prevention or new treatments and, ultimately, to prolong and enhance life.
Applications proposing novel approaches to the prevention, diagnosis, or treatment of leukemia, lymphoma, and myeloma are especially welcome. Proposals should be based on molecular, cellular, or integrated systems findings and be conceptually innovative.
The program is intended to provide support over an initial three-year period. In certain instances, funding for two additional years may be available.
Awards will be limited to a maximum of $200,000, which includes direct costs and a maximum overhead of $20,000, or 11.1 percent of direct costs, per year, for three years.
See the Leukemia & Lymphoma Society Web site for complete program information and application procedures.
RFP Link: http://fconline.fdncenter.org/pnd/527/lls
For additional RFPs in Medical Research, visit: http://fdncenter.org/pnd/rfp/cat_medical.jhtml
Fellowship Award - Damon Runyon Cancer Research Foundation
Deadline 3/15/05. This postdoctoral fellowship encourages all theoretical and experimental research relevant to the study of cancer and the search for cancer causes, mechanisms, therapies and prevention. For more information, visit the sponsor's website at: http://www.drcrf.org/apFellowship.html
Association for International Cancer Research
Internet Address: http://www.aicr.org.uk/information.stm
Health Topic Areas: Cancer research
Eligible Applicants: The application must come from a suitably qualified researcher (minimum of PhD). PhD students are only funded from within a project grant.
Description: AICR's aim is to support fundamental research into the causes, mechanisms, diagnosis, treatment and prevention of cancer. The emphasis is on basic, as opposed to clinical research.
Application Deadline: April 29, 2005; October 28, 2005
Contact Information:
AICR Grants Administration Office
Madras House
St Andrews, Fife, KY16 9EH
Tel: (01334) 477-910
Fax: (01334) 478-667
E-mail: alan.gilchrist@aicr.org.uk
Paul Marks Prize in Cancer Research
Deadline: April 29, 2005
The Memorial Sloan-Kettering Cancer Center is seeking nominations for the 2005 Paul Marks Prize in Cancer Research. The award recognizes investigators who have made significant contributions to understanding cancer or improving the treatment of cancer through basic or clinical research. The award consists of $150,000 and the deadline is April 29, 2005.
For more information, please visit the sponsor's website at: http://www.mskcc.org/mskcc/html/53983.cfm
This award does not require internal review, please apply directly to the sponsor. For a listing of other current funding opportunities, please visit our website at http://research.bcm.tmc.edu/award.htmAnnouncement of Grants for Cancer Center Pilot Projects
The BCM Cancer Center wishes to announce the availability of funding for Pilot Grants of $15,000 per year for 2 years. The funds are designated to support the early stage (or an expansion) of a collaborative project between two (or more) laboratories. The project should relate to cancer research, and preference will be given to applications with a strong potential for translational research. Project descriptions are limited to 5-6 pages not including references, but should be in a standard NIH grant format. The application should include specific aims, background & significance, preliminary studies, research design & methods, as well as a few references, in addition to a budget and budget justification, a biographical sketch and an other support page. Funds are not intended to provide PI salary support or to purchase equipment. Faculty at all levels are eligible to apply. Five copies of this application are due by 5:00 p.m. Monday, June 6, 2005. Applications should be delivered to Shari Stark, The Cancer Center, BCM Room 450A. Funding is available July 1, 2005.
For questions or additional information, please contact Ms. Stark at the Cancer Center, 713-798-2087.
ACS-IRG Seed Funds for Cancer Research
The Cancer Center is pleased to announce the availability of seed funds from the College's American Cancer Society Institutional Research Grant (IRG) #93-034-09. The funds support promising new cancer-related research projects by junior faculty. One-year grants in the amount of $20,000 will be awarded.
Applicants must be full-time, tenure-track assistant professors, appointed during the past five years (on or after January 1, 2000), who do not hold independent, nationally competitive research grants. Previous recipients of the Biomedical Research Support Grant or other BCM faculty seed funding programs are not eligible for funding.
Applications guidelines and forms are available on the Cancer Center website at www.bcm.edu/cancercenter under Funding Opportunities. Please submit proposals (original and five copies) by Monday, June 6, 2005 to Shari Stark, The Cancer Center, BCM Suite 450A.
Questions should be directed to Ms. Stark at (713) 798-2087 or sharir@bcm.tmc.edu.
Medical Student Stipend
American Cancer Society Institutional Research Grant (IRG) #93-034-09
A $2,500 stipend from the College's American Cancer Society IRG is available to a medical student to spend time in a research laboratory while still employed in his or her degree program. The research must relate to cancer.
Please submit the following to The Cancer Center by Monday, June 6, 2005:
One-page application outlining the proposed research*
Letter of recommendation from the mentor supervising the research
Personal Statement (not to exceed one page)
Official Medical School Transcript
*Application form can be downloaded from the Cancer Center webpage (www.bcm.edu/cancercenter) under the Funding Opportunities Section.
2005 ACS Medical Student Stipend Application
Susan G. Komen Interdisciplinary Breast Fellowship Program
This award does not require internal review, if you would like to submit an application, please submit it directly to the sponsor.
The Susan G. Komen Breast Cancer Foundation is accepting applications for the Interdisciplinary Breast Fellowship Program. This award is intended to prepare highly motivated, talented and compassionate physicians for careers devoted to serving the multispecialty needs of the breast cancer patient. The program will find two consecutive one-year fellowships at $35,000 per year. The application deadline if February 7, 2005.
For more information on this award, please visit the sponsor's website at:
http://www.komen.org/intradoc-cgi/idc_cgi_isapi.dll?IdcService=SS_GET_PAGE&nodeId=563
For other award opportunities, please visit the Intramural Funding & Awards website at: http://research.bcm.tmc.edu/award.htm
Cancer, Cardiovascular, Neuropsychiatry, Women in Medicine, Clinical, & Neuroscience Awards, Robert J. and Claire Pasarow Medical Prizes
Deadline 1/17/05 - $35,000. These awards are intended for investigators who have made extraordinary accomplishments in cancer research, cardiovascular research, or neuropsychiatry research. For more information of this award, please visit the following link: http://intranet.bcm.tmc.edu/index.cfm?tmp=research/oor/faaward/Pasarow.pdf
****************************************************************** NOTE: Faculty interested in applying for this award must have an acceptance letter from the Faculty Committee on Awards prior to submitting an application to the sponsor. For more information, please contact Emily Hughes in the Office of Research (713-798-6394 or ehughes@bcm.tmc.edu) or Kelly Livesay (713-798-6978 or klivesay@bcm.tmc.edu). ******************************************************************
Damon Runyon Cancer Research Foundation
Damon Runyon Scholar Award
Nominations for the Damon Runyon Scholar Award sponsored by the Damon Runyon Cancer Research Foundation are being accepted. The award supports the development of outstanding scientists as independent investigators in the cancer field by helping foster their research productivity during the first few years of their faculty position. The award is $100,000 per year for three years.
The primary qualification for this award is that the applicant's scientific accomplishments show promise of future contributions that will lead to understanding the causes and mechanisms of cancer and to developing more effective cancer therapies and preventions. To be eligible a candidate must:
- Be at the assistant professor or equivalent level
- Be within the first three years of his or her initial faculty appointment
- Not have another award expressly intended for career development running concurrently with the Damon Runyon Scholar Award. Non-U.S. citizens may apply only if they have a regular faculty appointment at a U.S. institution. Visiting appointments do not qualify.
An institution may nominate one physician-scientist (affiliated with a clinical department) and one basic scientist. If you would like to recommend someone for consideration by the Faculty Committee on Awards, please submit his or her curriculum vitae and a brief (not to exceed one page) summary of his or her research proposal via e-mail to awards@bcm.tmc.edu. A letter of nomination must also be submitted and may be sent via e-mail or interoffice mail to Emily Hughes, Office of Research, Room 600D. Nominations must be received by Friday, May 14, 2004.
For additional funding sources and award information, please see the Office of Research website (http://research.bcm.tmc.edu/Funding_Sources/funding_sources.html)
Bristol-Myers Squibb Award for Distinguished Achievement in Cancer Research
NOTE: Faculty interested in applying for this award must have an acceptance letter from the Faculty Committee on Awards prior to submitting an application. For more information, please contact Emily Hughes in the Office of Research at 713-798-6394 or ehughes@bcm.tmc.edu.
I am pleased to announce a request for nominations for the twenty-eighth annual Bristol-Myers Squibb Award for Distinguished Achievement in Cancer Research. The award recognizes a scientist who has made an outstanding contribution to progress in cancer research either in laboratory or clinical studies. Each recipient will receive a $50,000 prize and a silver commemorative medallion.
If you would like to recommend someone for consideration by the Faculty Committee on Awards, please send his or her curriculum vitae, a brief (not to exceed one page) summary of his or her applicable accomplishments, and a letter of nomination to Emily Hughes at awards@bcm.tmc.edu. Nominations must be received by Wednesday, September 15, 2004.
Ruth Anne Eatock, Ph.D.
Chair, Faculty Committee on Awards
For additional funding sources and award information, please see the BCM Office of Research website (http://research.bcm.tmc.edu/Funding_Sources/funding_sources.html)
2005 Introduction to Cancer Research Careers (ICRC) Program
Please see this brochure for details
Call for Applications for Pilot/Feasibility Projects for Novel Approaches to Prostate Cancer Research and Therapy.
The NIH/NCI-funded Specialized Program of Research Excellence (SPORE) in prostate cancer (SPORE P50-CA58204) supports translational research in prostate cancer. The Baylor Prostate Cancer SPORE is in the process of evaluating novel ideas for translational research, especially in the areas of molecular genetic approaches for human prostate cancer tissue-based research, novel uses of steroids and steroid antagonists (e.g., antiandrogens) in prostate cancer therapy, and novel immunomodulatory approaches to gene therapy for prostate cancer. We are therefore requesting proposals for pilot/feasibility projects that are related to these specific areas of research. Although preference will be given to these specific areas, outstanding proposals for work in other areas will be considered. Applicants should hold full-time faculty position at the College. The applications should be up to six pages, including references, and should follow a basic NIH format that includes the four-page NIH Biosketch and Research Support information. The request should not exceed $25,000 annually for a one-year funding period. The deadline for the receipt of applications is September 30th, 2004.
Please send your applications to:
Kellie Poudrier,
Administrator for the Baylor SPORE in Prostate Cancer,
Scott Department of Urology, Baylor College of Medicine,
6560 Fannin, Suite 2100,
Houston, TX 77030
(telephone: 713-799-8718;
fax: 713-794-7983;
Email: poudrier@bcm.tmc.edu).
NCI Cancer Prevention Fellowship Program Available
The NCI is offering Cancer Prevention Fellowship Programs. Per Douglas Weed, Director of the Cancer Prevention Fellowship Program, writes that the program offers postdoctoral training in the field of cancer prevention and control, including molecular prevention, biomarkers and early detection, molecular epidemiology, clinical trials, behavioral and nutritional interventions, and ethics of prevention. Two specialty tracks are available:
- Clinical Cancer Prevention Research
- Ethics of Prevention and Public Health
Fellows have the opportunity to receive Master of Public Health (M.P.H.) training at accredited university programs in the first year, followed by independent research at the NCI. Other programs activities are NCI's Summer Curriculum in Cancer Prevention, grant writing and effective presentation workshops, weekly prevention and control lectures, and fellows' research meetings.
To review their catalog online, please access: http://cancer.gov/prevention/pob. The deadline for the receipt of applications is September 1, 2004 for entrance into the program in the last week of June, 2005.
If you have any questions about the Program, please contact Dr. Weed or Mrs. Barbara Redding at (telephone) 301-496-8640, (fax) 301-402-4863 or (email) br24v@nih.gov
Concert for the Cure, Inc. Breast Cancer Research Grant
****************************************************************** NOTE: Faculty interested in applying for this award must have an acceptance letter from the Faculty Committee on Awards prior to submitting an application to the sponsor. For more information, please contact Emily Hughes in the Office of Research ((713) 798-6394 or ehughes@bcm.tmc.edu) or Kelly Livesay ((713) 798-6978 or klivesay@bcm.tmc.edu). ******************************************************************
Concert for the Cure, Inc.
Breast Cancer Research Grant
I am pleased to announce a request for nominations for the Breast Cancer Research Grant sponsored by Concert for the Cure, Inc. The grant provides up to $100,000 per year for up to three years to support an independent scientist involved in basic breast cancer research.
To be eligible, a candidate must plan to study the biology of cancer with the ultimate goal of clinical application of the discoveries. The candidate must be an independent laboratory investigator and must have independently assigned space. The duration of this independence must be less than three years as of January 2004.
If you would like to recommend someone for consideration by the Faculty Committee on Awards, please send a letter of nomination, his or her curriculum vitae, and a brief (not to exceed one page) summary of his or her proposed research project to Emily Hughes in the Office of Research (Room 600D). Nominations must be received by Wednesday, February 18, 2004.
Ruth Anne Eatock, Ph.D.
Chair, Faculty Committee on Awards